Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Cumberland Pharmaceuticals Inc. (CPIX) had Return on Equity of 4.40% for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
$11.71M |
|
$1.26M |
|
$1.43M |
|
$10.29M |
|
$10.42M |
|
$1.29M |
|
$-0.04M |
|
$1.25M |
|
$1.25M |
|
$1.25M |
|
$1.25M |
|
$1.25M |
|
$1.25M |
|
$1.29M |
|
$2.32M |
|
14.94M |
|
15.26M |
|
$0.08 |
|
$0.08 |
|
Balance Sheet Financials | |
$31.88M |
|
$0.30M |
|
$38.06M |
|
$69.94M |
|
$25.52M |
|
$5.24M |
|
$16.08M |
|
$41.60M |
|
$28.34M |
|
$10.44M |
|
$28.34M |
|
14.96M |
|
Cash Flow Statement Financials | |
$3.90M |
|
$-1.23M |
|
$-5.53M |
|
$17.96M |
|
$15.11M |
|
$-2.86M |
|
$0.07M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
0.16 |
|
0.18 |
|
87.83% |
|
11.03% |
|
11.03% |
|
-- |
|
10.70% |
|
10.73% |
|
$3.85M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.35 |
|
1.12 |
|
80.59 |
|
Return on Equity |
4.40% |
11.96% |
|
1.78% |
|
3.72% |
|
$1.89 |
|
$0.25 |
|
$0.26 |